Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2 BioPharma Stocks to Avoid, 1 to Buy
Motley Fool
Saturday, October 20, 2012 - 10:38am
tags:
Pfizer, Merck, JNJ
Aegerion CEO on Cholesterol Drug Lomitapide
Bloomberg
Saturday, October 20, 2012 - 10:37am
tags:
Aegerion, lomitapide, hypercholesterolemia
What Does This Rejection Mean for Obesity Drugmakers?
Motley Fool
Saturday, October 20, 2012 - 10:36am
tags:
Vivus, Qsymia, obesity, weight loss, Belviq, Arena Pharmaceuticals
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, October 20, 2012 - 10:33am
tags:
Isis Pharmaceuticals, Align Technology, MannKind
Celgene Corporation (CELG): Today's Featured Health Care Laggard
The Street
Saturday, October 20, 2012 - 10:32am
tags:
Celgene
1 Stem-Cell Spinout You Must Watch
Motley Fool
Saturday, October 20, 2012 - 10:32am
tags:
BioTime
Ziopharm slips on report that co withheld warning on trial data
Reuters
Saturday, October 20, 2012 - 10:31am
tags:
Ziopharm, soft tissue sarcomas, palifosfamide
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Saturday, October 20, 2012 - 10:29am
tags:
Biogen, BG-12, MS, multiple sclerosis
An FDA Decision Is on the MAP
Motley Fool
Saturday, October 20, 2012 - 10:28am
tags:
Levadex, MAP Pharmaceuticals, migraines
CRL/AstraZeneca Join Forces
Yahoo/Zacks
Saturday, October 20, 2012 - 10:27am
tags:
Charles River Laboratories, AstraZeneca
Earnings Beat at Cubist Pharma
Yahoo/Zacks
Saturday, October 20, 2012 - 10:26am
tags:
Cubist Pharmaceuticals, earnings
Amgen's Soaring, but Will Gravity Kick In?
Motley Fool
Saturday, October 20, 2012 - 10:26am
tags:
Amgen
PropThink: PBYI Makes a Big Splash on the NYSE; Why all the Excitement?
Yahoo/Reuters
Saturday, October 20, 2012 - 10:25am
tags:
Puma Biotechnology
Novo's long-acting insulin degludec takes big step to megamarket status
Fierce Biotech
Friday, October 19, 2012 - 12:20pm
tags:
degludec, Novo Nordisk, diabetes, insulin, Europe, Tresiba
Eli Lilly's Amyvid receives recommendation for approval from European committee
Yahoo/AP
Friday, October 19, 2012 - 12:17pm
tags:
Amyvid, Europe, Alzheimer's disease, Eli Lilly
Top 10 Pharma Layoffs of 2012
Fierce Pharma
Friday, October 19, 2012 - 11:46am
tags:
layoffs
Vivus Obesity Drug Fails to Win European Agency Backing
Bloomberg
Friday, October 19, 2012 - 11:45am
tags:
obsesity, Europe, Vivus, Qsiva, Qsymia
Lundbeck in Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Friday, October 19, 2012 - 11:34am
tags:
Lundbeck, Alzheimer's disease, M&A, Acrescent, AE58054
Bristol-Myers Squibb Third Quarter Earnings Preview
Investopedia.com
Friday, October 19, 2012 - 11:33am
tags:
earnings, Bristol-Myers Squibb
ISIS Pharma shares rise after FDA panel backs approval for cholesterol drug Kynamro
Yahoo/AP
Friday, October 19, 2012 - 11:21am
tags:
Isis Pharmaceuticals, FDA, advisory panels, Kynamro

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.